EDGAR Filing Documents for 0001437749-23-024546

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001437749-23-024546

Filing Date

2023-08-23

Accepted

2023-08-23 17:28:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM POS AM	pyxs20230818_posam.htm	POS AM	177260
2	EXHIBIT 4.2	ex_562698.htm	EX-4.2	90733
3	EXHIBIT 4.3	ex_562699.htm	EX-4.3	90772
4	EXHIBIT 4.4	ex_563856.htm	EX-4.4	213646
5	EXHIBIT 4.5	ex_562700.htm	EX-4.5	152577
6	EXHIBIT 4.6	ex_563857.htm	EX-4.6	46097
7	EXHIBIT 4.7	ex_562920.htm	EX-4.7	87335
8	EXHIBIT 5.1	ex_563859.htm	EX-5.1	12454
9	EXHIBIT 23.2	ex_563858.htm	EX-23.2	2635
10	EXHIBIT FILING FEES	ex_562692.htm	EX-FILING FEES	22260
11		pyxs20230818_posamimg001.jpg	GRAPHIC	4712
12		pyxs20230818_posamimg002.jpg	GRAPHIC	4712
13		sidley.jpg	GRAPHIC	2698
	Complete submission text file	0001437749-23-024546.txt		913815

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118

Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059

Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)